Weight Loss · Lisle, IL

Semaglutide for Weight Loss in Lisle, IL

Medically supervised semaglutide protocols, prescribed and monitored by our clinical team. Custom dosing, weekly check-ins, real accountability.

Book a Free Consultation

What Is Semaglutide?

Semaglutide is a GLP-1 receptor agonist FDA-approved for chronic weight management and type 2 diabetes. It is administered as a once-weekly subcutaneous injection (with a daily oral form also available for diabetes).

Generic name	Semaglutide
FDA approval (weight loss)	June 2021
Mechanism	GLP-1 receptor agonist
Administration	Once-weekly subcutaneous injection (with a daily oral tablet form also available for type 2 diabetes)
Typical dose range	0.25 mg to 2.4 mg (titrated over months)

The Science

How Semaglutide Works

GLP-1 receptor activation

Semaglutide mimics the natural hormone glucagon-like peptide-1 (GLP-1), which is released in the gut after eating. Activating these receptors triggers a chain of appetite and metabolic effects.

Reduced appetite

Semaglutide acts on appetite centers in the brain to reduce hunger and increase satiety. Most patients report eating less and feeling full sooner.

Slower gastric emptying

Semaglutide slows the rate at which the stomach empties, prolonging the feeling of fullness after meals and reducing blood sugar spikes.

Improved blood sugar control

Semaglutide stimulates insulin release when blood sugar is elevated and reduces glucagon production, which improves overall glucose regulation. This is why the same medication is used for both weight loss and type 2 diabetes.

Clinical Research

What Research Shows About Semaglutide

In the STEP-1 trial (published in the New England Journal of Medicine, 2021), adults with overweight or obesity who took 2.4 mg semaglutide weekly lost an average of 14.9% of their body weight over 68 weeks, compared to 2.4% in the placebo group.

Subsequent STEP trials confirmed these results in different populations. The SUSTAIN cardiovascular outcomes trial also found that semaglutide reduces the risk of major cardiovascular events (heart attack, stroke, cardiovascular death) in adults with type 2 diabetes.

Semaglutide was the first GLP-1 medication to demonstrate consistent weight loss above 10% in large randomized trials and remains one of the most-studied weight loss medications available.

Side-by-Side

Semaglutide vs Tirzepatide

Semaglutide and tirzepatide are the two most prescribed GLP-1 weight loss medications. Both are once-weekly injections, but their mechanisms and efficacy differ.

	Semaglutide	Tirzepatide
Mechanism	GLP-1 agonist only	Dual GIP / GLP-1 agonist
Average weight loss (highest dose)	~15%	~22.5%
FDA approval (weight loss)	2021	2023
Administration	Weekly injection or daily oral	Weekly injection

Learn about tirzepatide →

Our Program

How semaglutide works at Defiant.

Free Consultation

Meet with our medical team to discuss your goals, medical history, and whether semaglutide is right for you. No commitment.

Labs & Body Scan

Bring recent bloodwork from your PCP or Rythm Health. We review your labs and run a 3D body composition scan to establish your starting baseline.

Bi-Weekly Titration

Personalized semaglutide dosing with titration every two weeks — faster and more responsive than the monthly schedules most brands use. Adjusted around your labs, body composition, and response.

Ongoing Support

Weekly nurse check-ins, monthly body composition scans, and real-time dose adjustments as you progress.

Pricing

Custom GLP-1 Protocols from $295/mo

Includes medication, provider oversight, weekly nurse check-ins, and monthly body composition scans. Defiant members save 20%.

Book Your Consultation

Good Candidates

Who Semaglutide Is For

+ Adults with a BMI of 30 or higher
+ Adults with a BMI of 27 or higher with at least one weight-related condition (high blood pressure, type 2 diabetes, sleep apnea, cardiovascular disease)
+ People who have tried lifestyle changes without sustained results
+ Adults dealing with chronic inflammation or metabolic dysfunction — not just weight loss
+ People who are committed to lifestyle support alongside medication

Contraindications

Who Semaglutide Is Not For

− Pregnant or breastfeeding individuals
− Personal or family history of medullary thyroid carcinoma
− Multiple endocrine neoplasia syndrome type 2 (MEN-2)
− Severe gastrointestinal disease, including gastroparesis
− Active pancreatitis or history of pancreatitis

Our medical team reviews your full history before prescribing. This is not an exhaustive list of contraindications.

FAQ

Semaglutide Questions

Plain-language answers to the most common questions about semaglutide treatment at Defiant in Lisle, IL.

Semaglutide is a prescription GLP-1 receptor agonist medication FDA-approved for chronic weight management and type 2 diabetes. It is most commonly administered as a once-weekly subcutaneous injection.

The active ingredient is the same. The difference is dose and FDA-approved use. For chronic weight management, semaglutide is dosed up to 2.4 mg weekly. For type 2 diabetes, it is typically dosed up to 2.0 mg weekly. Both work through the same mechanism (GLP-1 receptor activation) and produce many of the same effects on appetite and blood sugar.

In the STEP-1 clinical trial, participants on 2.4 mg semaglutide weekly lost an average of 14.9% of their body weight over 68 weeks, compared to 2.4% in the placebo group. Individual results vary based on dose, duration, lifestyle factors, and adherence.

The main difference is mechanism. Semaglutide activates only the GLP-1 receptor. Tirzepatide activates both the GLP-1 and GIP receptors. In clinical research, tirzepatide has produced greater average weight loss (about 22.5% at the highest dose) than semaglutide (about 15% at its highest dose). Semaglutide has a longer track record and may be a better fit for some patients based on side effect profile, cost, or insurance coverage.

The most common side effects are gastrointestinal: nausea, diarrhea, constipation, vomiting, and abdominal discomfort. These are usually mild to moderate and most common during dose escalation. Serious but rare side effects include pancreatitis, gallbladder problems, and kidney problems. Semaglutide carries a boxed warning for thyroid C-cell tumors.

Most patients notice reduced appetite within the first 1 to 2 weeks. Meaningful weight loss typically begins within the first month and continues over 3 to 6 months with continued treatment. The full effect generally takes 12 to 18 months of consistent use.

Yes. Semaglutide is a prescription-only medication. At Defiant Health, our medical team evaluates whether semaglutide is appropriate for you based on your recent bloodwork (from your PCP or Rythm Health), body composition, medical history, and goals.

Our Custom GLP-1 Protocols, including semaglutide, start at $295 per month. Defiant members save 20%. Pricing includes the medication, provider oversight, weekly nurse check-ins, and monthly body composition scans.

Research from the STEP-4 trial suggests that most people regain a significant portion of lost weight after stopping semaglutide. For long-term weight management, ongoing treatment combined with lifestyle support is typically required.

Defiant Health offers semaglutide weight loss programs at our clinic in Lisle, IL, serving Naperville, Downers Grove, Wheaton, Bolingbrook, Lombard, and the greater Chicago western suburbs. Book a free consultation to determine if semaglutide is right for you.

Get Started

Semaglutide Weight Loss in Chicago’s Western Suburbs

Defiant Health offers semaglutide weight loss programs at our Lisle, IL clinic — serving Naperville, Downers Grove, Wheaton, Bolingbrook, Lombard, and the greater Chicago western suburbs.